ZYMO RESEARCH CORPORATION

Zymo Research Corporation specializes in advanced genomic and epigenomic analysis services, delivering cutting-edge laboratory solutions for federal research and regulatory agencies. Their core capabilities center on high-throughput sequencing technologies, including shotgun metagenomic sequencing, ChIP-seq, and locus-specific methylation analysis, with deep expertise in bioinformatics pipeline development and sample preparation for complex biological samples. They provide end-to-end solutions from molecular assay design to data interpretation, leveraging proprietary reagent kits and analytical platforms optimized for low-input and degraded samples. A key differentiator is their focus on epigenetic biomarker discovery and quantitative methylation profiling, supporting applications in environmental health, clinical diagnostics, and infectious disease surveillance. The company maintains strong relationships with the Department of Health and Human Services, where they deliver epigenomic sequencing services for NIH institutes such as NICHD, and with the Department of Veterans Affairs, providing clinical-grade ChIP-seq for translational research. They also support the Environmental Protection Agency with reagent validation and analytical instrument compliance, while collaborating with the Department of Agriculture on bioinformatics pipelines for agricultural microbiome studies and the Department of Defense on targeted methylation analysis for biomarker identification in military-relevant contexts. Zymo Research operates primarily under NAICS 541714, focusing on biotechnology research and development, with complementary work in medical laboratories and analytical testing services. Their market positioning is defined by niche expertise in epigenetics and metagenomics, serving government-funded initiatives in precision health, environmental monitoring, and biomedical innovation. As a Women-Owned Small Business based in Irvine, California, Zymo Research is certified as a Woman-Owned Business and brings specialized technical agility to federal science and health missions. Their geographic presence and certification status enhance their accessibility to set-aside opportunities and mission-critical R&D contracts across the federal landscape.